Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-26 @ 7:06 PM
Study NCT ID:
NCT01148459
Status:
COMPLETED
Last Update Posted:
2019-01-16
First Post:
2010-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07-30
Start Date Type:
None
Primary Completion Date:
2013-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2010-06-17
First Submit QC Date:
None
Study First Post Date:
2010-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-08
Results First Submit QC Date:
None
Results First Post Date:
2019-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-30
Last Update Post Date:
2019-01-16
Last Update Post Date Type:
ACTUAL